MaaT Pharma SA (EPA:MAAT)

MaaT Pharma Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Assets

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	24.87	20.15	24.28	35.25	43.3
Short-Term Investments	0.1	0.07	0.2	0.3	0.1
Cash & Short-Term Investments	24.96	20.22	24.48	35.55	43.4
Cash Growth	23.45%	-17.40%	-31.14%	-18.10%	116.88%
Accounts Receivable	1.37	1.32	0.36	0.71	0.39
Other Receivables	6.58	6.04	5.97	4.45	3.06
Total Trade Receivables	7.95	7.36	6.33	5.15	3.45
Inventory	0.08	0.06	0.19	0.06	0.07
Other Current Assets	-	-	3.24	1.55	0.4
Total Current Assets	32.99	27.64	34.24	42.31	47.33
Net Property, Plant & Equipment	7.34	8.6	1.19	0.56	0.53
Other Intangible Assets	1.84	1.77	0.32	0.17	0.13
Long-Term Investments	0.38	0.49	0.17	0.11	-
Other Long-Term Assets	2	-	0.27	0.24	0.17
Total Assets	44.55	38.5	36.19	43.4	48.16

Liabilities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	11.81	8.83	6.44	4.56	2.43
Accrued Expenses	-	-	1.31	1.19	0.8
Current Portion of Long-Term Debt	2.49	3.13	-	-	-
Unearned Revenue	-	-	-	15.29	6.81
Other Current Liabilities	2.67	2.61	0.24	0.4	0.27
Total Current Liabilities	16.98	14.56	7.99	21.45	10.3
Long-Term Debt	14.95	12.83	6.84	9.23	3.44
Other Long-Term Liabilities	10.83	0.78	0.04	0.09	0.12
Total Long-Term Liabilities	25.78	13.6	6.88	9.32	3.57
Total Liabilities	42.75	28.17	7.95	6.06	3.37

Shareholders' Equity

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	1.89	1.4	1.16	0.99	0.99
Additional Paid-in Capital	28.77	35.48	37.38	38.32	46.46
Retained Earnings	-28.85	-26.54	-18.92	-13.37	-8.24
Total Common Shareholders' Equity	1.8	10.34	19.62	25.95	39.22
Minority Interest	-	-	1.74	2.06	2.01
Shareholders' Equity	1.8	10.34	19.73	26.01	39.23
Total Liabilities & Equity	44.55	38.5	36.19	43.4	48.16

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	17.44	15.96	6.84	9.23	3.44
Net Cash (Debt)	7.52	4.26	17.64	26.32	39.96
Net Cash Growth	76.45%	-75.83%	-32.99%	-34.14%	147.21%
Net Cash Per Share	0.47	0.33	1.55	2.66	16.47
Book Value	1.8	10.34	19.62	25.95	39.22
Book Value Per Share	0.11	0.79	1.73	2.62	16.16
Tangible Book Value	-0.05	8.57	19.3	25.77	39.09
Tangible Book Value Per Share	-0.00	0.66	1.70	2.61	16.11

Data Source: Fiscal.ai Last updated: Apr 11, 2025

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 31, 2026

Data Sources Report a data error